Ogawa M
Gan To Kagaku Ryoho. 1985 Feb;12(2):179-88.
This review describes the current clinical results of phase I and II trials of new antitumor drugs such as the new anthracyclines: epirubicin, idarubicin, esorubicin, carminomycin and marcellomycin; the second generation cisplatin: carboplantin, CHIP, TNO-6, DACCP and JM-40; mitoxantrone, AMSA, AZQ, Tiazofurin, DFMO and others.
本综述描述了新型抗肿瘤药物如新型蒽环类药物（表柔比星、伊达比星、依索比星、卡米诺霉素和马塞洛霉素）、第二代顺铂（卡铂、CHIP、TNO - 6、DACCP和JM - 40）、米托蒽醌、AMSA、AZQ、替拉扎明、二氟甲基鸟氨酸等的I期和II期临床试验的当前临床结果。
